Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca Rocca

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Clinical and Translational Science|October 6, 2022
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulationGiovanna Petrucci, Alberto Giaretta, Paola Ranalli, et al.
Blood|January 12, 2012
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug targetSilvia Pascale, Giovanna Petrucci, Alfredo Dragani, et al.
Journal of the American College of Cardiology|September 30, 2017
Antiplatelet Agents for the Treatment and Prevention of Coronary AtherothrombosisCarlo Patrono, Joao Morais, Colin Baigent, et al.
Free Radical Biology & Medicine|December 9, 2009
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stressStefano Lancellotti, Vincenzo De Filippis, Nicola Pozzi, et al.
Haematologica|July 18, 2009
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemiaKun Liu, Maurizio Martini, Bianca Rocca, et al.
European Heart Journal|March 25, 2021
Antithrombotic therapy in diabetes: which, when, and for how long?Ramzi A Ajjan, Noppadol Kietsiriroje, Lina Badimon, et al.
British Journal of Haematology|March 16, 2004
In vivo and in vitro effects of different anaesthetics on platelet functionPier Lorenza Dordoni, Luciano Frassanito, Maria F Bruno, et al.
European Cardiology|April 2, 2025
Cardio-oncology: Emerging Concepts in Cardiovascular Sequelae of Cancer Therapies, Translational Research and Reverse Cardio-oncologyMassimiliano Camilli, Luca Maggio, Lorenzo Tinti, et al.
Scientific Reports|March 6, 2024
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B<sub>2</sub> and 8-iso-prostaglandin F<sub>2α,</sub> levels in human urine samples by validated enzyme immunoassaysGiovanna Petrucci, Duaa Hatem, Ruth Langley, et al.
European Heart Journal|February 22, 2024
Thromboxane biosynthesis and future events in diabetes: the ASCEND trialGiovanna Petrucci, Georgina A Buck, Bianca Rocca, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Clinical and Translational Science|October 6, 2022
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulationGiovanna Petrucci, Alberto Giaretta, Paola Ranalli, et al.
Blood|January 12, 2012
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug targetSilvia Pascale, Giovanna Petrucci, Alfredo Dragani, et al.
Journal of the American College of Cardiology|September 30, 2017
Antiplatelet Agents for the Treatment and Prevention of Coronary AtherothrombosisCarlo Patrono, Joao Morais, Colin Baigent, et al.
Free Radical Biology & Medicine|December 9, 2009
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stressStefano Lancellotti, Vincenzo De Filippis, Nicola Pozzi, et al.
Haematologica|July 18, 2009
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemiaKun Liu, Maurizio Martini, Bianca Rocca, et al.
European Heart Journal|March 25, 2021
Antithrombotic therapy in diabetes: which, when, and for how long?Ramzi A Ajjan, Noppadol Kietsiriroje, Lina Badimon, et al.
British Journal of Haematology|March 16, 2004
In vivo and in vitro effects of different anaesthetics on platelet functionPier Lorenza Dordoni, Luciano Frassanito, Maria F Bruno, et al.
European Cardiology|April 2, 2025
Cardio-oncology: Emerging Concepts in Cardiovascular Sequelae of Cancer Therapies, Translational Research and Reverse Cardio-oncologyMassimiliano Camilli, Luca Maggio, Lorenzo Tinti, et al.
Scientific Reports|March 6, 2024
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B<sub>2</sub> and 8-iso-prostaglandin F<sub>2α,</sub> levels in human urine samples by validated enzyme immunoassaysGiovanna Petrucci, Duaa Hatem, Ruth Langley, et al.
European Heart Journal|February 22, 2024
Thromboxane biosynthesis and future events in diabetes: the ASCEND trialGiovanna Petrucci, Georgina A Buck, Bianca Rocca, et al.
Pageof 16